GP6 and ovarian carcinoma: Using CRISPR-Cas9 knockout (KO) cancer cells, our platform revealed that platelets might promote ovarian cancer metastasis and chemoresistance through a shear-dependent interaction of their GPVI with galectin-3 expressed on the cancer cells.